This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxo Group Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Vesna Erakovic Haber: Innovator in Anti-Inflammatory Macrolides
Introduction
Vesna Erakovic Haber is a notable inventor based in Rijeka, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides with anti-inflammatory activity. Her work is crucial in addressing various inflammatory diseases and conditions.
Latest Patents
Vesna holds a patent for "Macrolides with anti-inflammatory activity." This invention pertains to novel semi-synthetic macrolides that exhibit anti-inflammatory properties. Specifically, it focuses on 14- and 15-membered macrolides substituted at the 4″ position, along with their pharmaceutically acceptable derivatives. The patent also covers processes and intermediates for their preparation, as well as pharmaceutical compositions containing these compounds. The invention is particularly relevant for treating inflammatory diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2, or IL-5, and for inhibiting excessive lymphocyte proliferation and granulocyte degranulation. Vesna has 1 patent to her name.
Career Highlights
Vesna is currently associated with Glaxo Group Limited, where she continues her research and development efforts. Her work has positioned her as a key player in the pharmaceutical industry, contributing to advancements in treatments for inflammatory conditions.
Collaborations
Throughout her career, Vesna has collaborated with esteemed colleagues, including Sulejman Alihodzic and Martina Bosnar. These partnerships have enhanced her research and broadened the impact of her innovations.
Conclusion
Vesna Erakovic Haber is a pioneering inventor whose work in macrolides has the potential to transform the treatment of inflammatory diseases. Her contributions to the pharmaceutical field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
